SEMI vs. PBE ETF Comparison

Comparison of Columbia Seligman Semiconductor and Technology ETF (SEMI) to PowerShares Dynamic Biotech & Genome (PBE)
SEMI

Columbia Seligman Semiconductor and Technology ETF

SEMI Description

SEMI is designed to provide exposure to the broad information technology sector by focusing on pure-play companies related to the semiconductor industry. The fund actively and generally invests in 30-50 high-conviction semiconductor or semiconductor-related firms, as defined by GICS, including those under communication equipment, electronic equipment, technology hardware, storage and peripherals, and software. Additionally, the fund requires at least 25% of its assets be invested in companies in the semiconductor and semiconductor equipment industry. Security selection is done through extensive in-depth research. SEMI is a non-transparent ETF and does not provide daily disclosure of its portfolio holdings unlike other ETFs. As such, there is a risk that shares of the fund may trade at wider spreads, especially during periods of volatility. The fund instead publishes a trading basket daily, which provides a preview of selected holdings without disclosing the actual portfolio.

Grade (RS Rating)

Last Trade

$24.76

Average Daily Volume

4,651

Number of Holdings *

33

* may have additional holdings in another (foreign) market
PBE

PowerShares Dynamic Biotech & Genome

PBE Description The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$64.06

Average Daily Volume

17,493

Number of Holdings *

30

* may have additional holdings in another (foreign) market
Performance
Period SEMI PBE
30 Days -1.43% 1.23%
60 Days -0.06% -3.98%
90 Days 11.06% -0.07%
12 Months 47.10% 2.88%
0 Overlapping Holdings
Symbol Grade Weight in SEMI Weight in PBE Overlap
SEMI Overweight 33 Positions Relative to PBE
Symbol Grade Weight
LRCX D 7.94%
AVGO D 6.78%
SMTC A 5.87%
NVDA C 4.8%
AMAT C 4.47%
MRVL D 4.47%
ADI A 4.46%
KLAC B 4.14%
NXPI A 4.0%
ON F 3.81%
MU B 3.69%
MCHP A 3.28%
QCOM A 3.16%
TER A 3.12%
WDC B 3.01%
INDI F 2.92%
TSM C 2.7%
QRVO F 2.33%
SYNA D 2.18%
STM F 2.01%
INTC F 1.97%
AEIS D 1.9%
BE C 1.72%
CDNS D 1.45%
SNPS D 1.45%
SWKS F 1.26%
SGH F 0.98%
AMD D 0.73%
ICHR D 0.64%
MKSI D 0.54%
KLIC D 0.49%
DIOD C 0.48%
ENTG D 0.43%
SEMI Underweight 30 Positions Relative to PBE
Symbol Grade Weight
TECH C -5.41%
NBIX A -5.3%
REGN B -4.98%
AMGN A -4.94%
BIIB D -4.9%
VRTX D -4.79%
BMRN F -4.75%
GILD F -4.56%
PTCT B -3.55%
TGTX C -3.41%
MNKD D -3.34%
UTHR A -3.31%
BPMC A -3.22%
COLL C -3.21%
HALO D -3.03%
CPRX D -2.99%
EXEL D -2.94%
CLDX C -2.91%
QGEN C -2.74%
IONS F -2.67%
VCEL C -2.65%
DVAX D -2.62%
ITCI C -2.62%
XENE C -2.44%
RGEN D -2.28%
MYGN D -2.24%
VCYT D -2.21%
FOLD F -2.09%
EYPT D -1.97%
ACAD F -1.89%
Compare ETFs